CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
Sleep-disordered breathingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03026634
NCT03026634N/ACompleted

Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation - a Prospective Single Center Trial

Heart and Diabetes Center North-Rhine Westfalia·observational·Posted Jan 20, 2017·Updated May 6, 2021

In Brief

An observational study evaluating Sleep-disordered breathing for Sleep Disordered Breathing Central and 2 related conditions. Completed, enrolled 500 participants across 1 site.

Detailed Summary

Sleep-disordered breathing is believed to appear at a high prevalence in end-stage heart failure patients and the presence of sleep-disordered breathing has been associated with increased mortality. This study is designed to investigate prevalence and dynamics of sleep-disordered breathing in end-stage heart failure patients pre and post heart transplantation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 20, 2017
Enrollment StartJan 1, 2017
Primary CompletionOct 9, 2020
Study CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 9.5 years ago

Interventions

Sleep-disordered breathingbehavioral

Prevalence and dynamic of sleep-disordered breathing after heart transplantation